• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2022 Fiscal Year Annual Research Report

Development of clinical-fit aptamer targeting CYP24A1 using an integrated approach of high-speed atomic force microscopy and molecular docking

Research Project

Project/Area Number 21K15239
Research InstitutionKanazawa University

Principal Investigator

Biyani Madhu  金沢大学, ナノ生命科学研究所, 特任助教 (30882245)

Project Period (FY) 2021-04-01 – 2023-03-31
KeywordsCYP24 / Aptamer / Vitamin D3
Outline of Annual Research Achievements

Vitamin D3 is metabolized to 1α, 25-dihydroxy vitamin D3 (1,25D3), which exerts various physiological effects such as bone formation, cell proliferation, and differentiation. Thus, 1,25D3 and its analogs have been clinically used as therapeutic agents against rickets and psoriasis, furthermore, they have been also expected as cancer treatments. CYP24A1 (CYP24) is a key enzyme that catalytically degrades the 1,25-D3, thus overexpression of CYP24 leads the various types of diseases such as osteoporosis and cancer. Aptamer Apt-7 has shown high binding affinity, specificity, and inhibitory potency against CYP24 as well as anti-proliferative ability in vitro and in cellular assays. Next, we evaluated Apt-7 by in vivo study. To enhance the nucleases resistance in vivo, we designed and developed a circular bivalent version of Apt-7, called Cb-7, and performed systematic studies of Cb-7. Cb-7 showed high nuclease stability with increased functional activity and remarkable anti-proliferative effects in lung cancer cell line A549 cells. As a preliminary test, we investigated Cb-7 in vivo. We established an evaluation system of a xenograft mouse model with A549 cells. 1,25D3 was administered intraperitoneally three times a week, while Cb-7 was administrated directly into the tumor three times a week only in the tumor of the left shoulder. As the result, the tumor volume of the left shoulder (with Cb-7) showed a tendency to decrease. However, further study is needed in the future.

  • Research Products

    (3 results)

All 2023 2022

All Journal Article (2 results) (of which Int'l Joint Research: 2 results,  Peer Reviewed: 1 results,  Open Access: 1 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] Highlights from the 24th workshop on vitamin D in Austin, September 20222023

    • Author(s)
      Meyer Mark B.Biyani Madhu、Campbell Moray J.、Chaudhari Snehal N.、Christakos Sylvia、Ingles Sue A.、Knuth Megan M.、Lee Seong Min、Lisse Thomas S.、Liu Eva S.、Piec Isabelle、Plum Lori A.、Rao Sudhaker D.、Reynolds Carmen J.、Thacher Tom D.、White John H.、Cantorna Margherita T.
    • Journal Title

      The Journal of Steroid Biochemistry and Molecular Biology

      Volume: 228 Pages: 106247~106247

    • DOI

      10.1016/j.jsbmb.2023.106247

    • Open Access / Int'l Joint Research
  • [Journal Article] Novel DNA Aptamer for CYP24A1 Inhibition with Enhanced Antiproliferative Activity in Cancer Cells2022

    • Author(s)
      Biyani Madhu、Yasuda Kaori、Isogai Yasuhiro、Okamoto Yuki、Weilin Wei、Kodera Noriyuki、Flechsig Holger、Sakaki Toshiyuki、Nakajima Miki、Biyani Manish
    • Journal Title

      ACS Applied Materials & Interfaces

      Volume: 14 Pages: 18064~18078

    • DOI

      10.1021/acsami.1c22965

    • Peer Reviewed / Int'l Joint Research
  • [Patent(Industrial Property Rights)] 特願2021-0829042022

    • Inventor(s)
      Madhu, Yasuda, Manish
    • Industrial Property Rights Holder
      Madhu, Yasuda, Manish
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      20210511_T20120-01

URL: 

Published: 2023-12-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi